Arens Timothy J.

Avg. Two Year Performance

No purchase track record
(27%) Avg. Sale Return
(13%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(8%)(30%)(30%)(9%)(27%)
Sale Success Rate0 of 30 of 30 of 30 of 30 of 3

SurModics Inc.

Drugs » Diagnostic Substances

Chief Financial Officer:

Holdings: 77.36K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--